Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction

Código QR

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction

Background: We aim to investigate the guideline adherence of β-blocker (BB) initiating dose in Chinese hospitalized patients with heart failure with reduced ejection fraction (HFrEF) and whether the adherence affected the in-hospital outcomes.Methods: This was a retrospective study of patients hospi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yiling Zhou, Yuping Zeng, Si Wang, Nan Li, Miye Wang, Ify R. Mordi, Yan Ren, Youlian Zhou, Ye Zhu, Haoming Tian, Xin Sun, Xiaoping Chen, Zhenmei An, Chim C. Lang, Sheyu Li
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	inverse probability weighting heart failure heart failure with reduced ejection fraction hospitalization beta blocker adverse events < patient safety Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/3606d45704e14ee780f7e897a5a7dcd6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Marat Fudim, et al.
Publicado: (2021)

Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
por: Domingo Pascual-Figal, et al.
Publicado: (2021)

A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
por: Swapan Sarkar, et al.
Publicado: (2021)

A Universal New Definition of Heart Failure With Improved Ejection Fraction for Patients With Coronary Artery Disease
por: Haozhang Huang, et al.
Publicado: (2021)

Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
por: Milos Taborsky, et al.
Publicado: (2021)

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial
por: Carolyn S. P. Lam, et al.
Publicado: (2021)

Recent and Upcoming Drug Therapies for Pediatric Heart Failure
por: Karla L. Loss, et al.
Publicado: (2021)

Interatrial shunt devices for heart failure with normal ejection fraction: a technology update
por: Cuthbert JJ, et al.
Publicado: (2017)

Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania
por: Gyalai-Korpos I, et al.
Publicado: (2015)

Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
por: Amy Hyein Kim, et al.
Publicado: (2022)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Satoshi Yanagisawa, et al.
Publicado: (2010)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Steffen Pabel, et al.
Publicado: (2021)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
por: Wan Ting Tay, et al.
Publicado: (2021)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Li-fang Ye, et al.
Publicado: (2021)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: Arno A. van de Bovenkamp, et al.
Publicado: (2021)

Valor pronóstico de la hiperuricemia en la insuficiencia cardíaca crónica
por: Martínez S,Alejandro, et al.
Publicado: (2004)

Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation
por: P. P. Bidzilya, et al.
Publicado: (2021)

Race and Beta‐Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self‐Reported Race and Proportion of African Genetic Ancestry
por: Jasmine A. Luzum, et al.
Publicado: (2018)

Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction
por: Zheng,Huan, et al.
Publicado: (2014)

Vagal Neuromodulation in Chronic Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis
por: Lucas Bonacossa Sant'Anna, et al.
Publicado: (2021)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
por: Dzhioeva O, et al.
Publicado: (2020)

Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania
por: Mavrea AM, et al.
Publicado: (2015)

Cardiac MRI Based Left Ventricular Global Function Index: Association with Disease Severity in Patients with ICD for Secondary Prevention
por: Andreas Leonhard Schober, et al.
Publicado: (2021)

Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials
por: Johannes Grand, et al.
Publicado: (2021)

Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis
por: Yibo He, et al.
Publicado: (2021)

Tricuspid insufficiency after cardiac-implantable electronic device placement
por: Nismat Javed, et al.
Publicado: (2021)

Clinical Outcomes of Patients with Coronary Artery Diseases and Moderate Left Ventricular Dysfunction: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery
por: Wang S, et al.
Publicado: (2021)

The Effects of Hypertension Stages on N-Terminal-Pro Brain Natriuretic Peptide (NT-Pro-BNP) Level and Left Ventricular Ejection Fraction
por: Kati Sriwiyati, et al.
Publicado: (2019)

Reduced ejection fraction heart failure – new data from multicenter studies and national registries regarding general and elderly populations: hopes and disappointments
por: Crișan S, et al.
Publicado: (2018)

European journal of heart failure. journal of the Working Group on Heart Failure of the European Society of Cardiology.
Publicado: (2002)

Dapagliflozin in the treatment of patients with heart failure with reduced left ventricular ejection fraction – a practical approach
por: Jadwiga Nessler
Publicado: (2021)

European journal of heart failure
Publicado: (1999)

Left ventricular assistant devices for end-stage heart failure: report of two cases
por: Pedemonte,Oneglio, et al.
Publicado: (2014)

The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting
por: Blanka Morvai-Illés, et al.
Publicado: (2021)

Comparison of Pharmacological Treatment Effects on Long-Time Outcomes in Heart Failure With Preserved Ejection Fraction: A Network Meta-analysis of Randomized Controlled Trials
por: Yaowang Lin, et al.
Publicado: (2021)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
por: M. A. Manukyan, et al.
Publicado: (2021)

Asistencia ventricular mecánica como puente al trasplante en pacientes en shock cardiogénico: Experiencia preliminar en Chile con ABIOMED BVS 5000®
por: Castro G,Pablo, et al.
Publicado: (2006)

Pacientes elegibles para las nuevas terapias de la insuficiencia cardíaca en un policlínico especializado
por: Rossel,Víctor, et al.
Publicado: (2019)

Disfunción miocárdica en la sepsis
por: ANDRESEN,MAX, et al.
Publicado: (2010)

The prognostic role of high-sensitivity cardiac troponin T over time in ischemic and non-ischemic heart failure
por: Siyuan Li, et al.
Publicado: (2021)